FDA approves two new Abbott over-the-counter continuous glucose monitors

Abbott on Monday announced it has received FDA clearance for two new CGMs that will be available without a prescription.

Abbott’s new Libre Rio system is for patients with Type 2 diabetes that do not take insulin, while Lingo is designed for use by consumers that are trying to improve their health and wellness.